SynthesisFrontiers in cardiovascular medicine2024

Efficacy and safety of cardiac myosin inhibitors for symptomatic hypertrophic cardiomyopathy: a meta-analysis of randomized controlled trials.

Anas Abunada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.